Literature DB >> 21380519

Levosimendan: from coronary care to intensive care?

Karen Stuart-Smith.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21380519     DOI： 10.1007/s00134-011-2204-6

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  18 in total

1.  A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart.

Authors:  E F du Toit; A Genis; L H Opie; P Pollesello; A Lochner
Journal:  Br J Pharmacol       Date:  2008-02-25       Impact factor: 8.739

2.  Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.

Authors:  Andrea Morelli; Stefano De Castro; Jean-Louis Teboul; Mervyn Singer; Monica Rocco; Giorgio Conti; Leonardo De Luca; Emanuele Di Angelantonio; Alessandra Orecchioni; Natesa G Pandian; Paolo Pietropaoli
Journal:  Intensive Care Med       Date:  2005-04-06       Impact factor: 17.440

Review 3.  Mechanisms of action of calcium-sensitizing drugs.

Authors:  H Haikala; I B Linden
Journal:  J Cardiovasc Pharmacol       Date:  1995       Impact factor: 3.105

4.  Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.

Authors:  Patricia N Banfor; Lee C Preusser; Thomas J Campbell; Kennan C Marsh; James S Polakowski; Glenn A Reinhart; Bryan F Cox; Ryan M Fryer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2007-11-02       Impact factor: 4.733

5.  Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers.

Authors:  Claes-Håkan Bergh; Bert Andersson; Ulf Dahlström; Kolbjorn Forfang; Matti Kivikko; Toni Sarapohja; Bengt Ullman; Gerhard Wikström
Journal:  Eur J Heart Fail       Date:  2010-04       Impact factor: 15.534

6.  Inotropic support during experimental endotoxemic shock: part I. The effects of levosimendan on splanchnic perfusion.

Authors:  Doris Cunha-Goncalves; Valeria Perez-de-Sa; Edgars Grins; Peter L Dahm; Johan Thörne; Sten Blomquist
Journal:  Anesth Analg       Date:  2009-08-27       Impact factor: 5.108

7.  Inotropic support during experimental endotoxemic shock: part II. A comparison of levosimendan with dobutamine.

Authors:  Doris Cunha-Goncalves; Valeria Perez-de-Sa; Anders Larsson; Johan Thörne; Sten Blomquist
Journal:  Anesth Analg       Date:  2009-08-27       Impact factor: 5.108

Review 8.  Vasodilating mechanisms of levosimendan: involvement of K+ channels.

Authors:  Oguzhan Yildiz
Journal:  J Pharmacol Sci       Date:  2007-04-24       Impact factor: 3.337

9.  Levosimendan pre-treatment improves outcomes in patients undergoing coronary artery bypass graft surgery.

Authors:  L Tritapepe; V De Santis; D Vitale; F Guarracino; F Pellegrini; P Pietropaoli; M Singer
Journal:  Br J Anaesth       Date:  2009-02       Impact factor: 9.166

10.  The effects of levosimendan and glibenclamide on circulatory and metabolic variables in a canine model of acute hypoxia.

Authors:  Lothar A Schwarte; Ingo Schwartges; Kai Thomas; Patrick Schober; Olaf Picker
Journal:  Intensive Care Med       Date:  2011-03-05       Impact factor: 17.440
View more
  2 in total

1.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440

2.  Levosimendan inhibits release of reactive oxygen species in polymorphonuclear leukocytes in vitro and in patients with acute heart failure and septic shock: a prospective observational study.

Authors:  Julia Hasslacher; Klaudija Bijuklic; Cristina Bertocchi; Jordan Kountchev; Romuald Bellmann; Stefan Dunzendorfer; Michael Joannidis
Journal:  Crit Care       Date:  2011-07-12       Impact factor: 9.097
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.